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Abstract
Progesterone receptor and estrogen receptor participate in growth and differentiation of
the different rat decidual regions. Steroid hormone receptor antagonists were used to
study steroid regulation of decidualization. Here we describe a suppressive interaction be-
tween progesterone receptor (onapristone) and estrogen receptor (ICI182780) antagonists
and their relation to a rescue phenomenon with concomitant regulation of Hand2, Bmp2
and p-ERK1/2 during the early decidualization steps. Phenotypes of decidua development
produced by antagonist treatments were characterized by morphology, proliferation, dif-
ferentiation, angiogenesis and expression of signaling molecules. We found that suppres-
sion of progesterone receptor activity by onapristone treatment resulted in resorption of
the implantation sites with concomitant decrease in progesterone and estrogen receptors,
PCNA, KI67 antigen, DESMIN, CCND3, CX43, Prl8a2, and signaling players such as
transcription factor Hand2, Bmp2mRNAs and p-ERK1/2. Moreover, FGF-2 and Vegfa in-
creased as a consequence of onapristone treatment. Implantation sites from antagonist of
estrogen receptor treated rats developed all decidual regions, but showed an anomalous
blood vessel formation at the mesometrial part of the decidua. The deleterious effect of
onapristone was partially counteracted by the impairment of estrogen receptor activity with
rescue of expression levels of hormone steroid receptors, proliferation and differentiation
markers, and the induction of a probably compensatory increase in signaling molecules
Hand2, Bmp2 and ERK1/2 activation compared to oil treated controls. This novel drug in-
teraction during decidualization could be applied to pathological endometrial cell prolifera-
tion processes to improve therapies using steroid hormone receptor targets.
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Introduction
The uterus provides a unique and dynamic physiological model in which cellular proliferation,
differentiation and apoptosis occur in a spatiotemporal and cell-specific manner during preg-
nancy. Decidualization comprises a rapid remodeling of the uterine stromal compartment re-
sulting in a morphological and functional transformation [1, 2]. This complex shift in the cell
program builds the decidua, a specialized compact tissue responsible for successful implanta-
tion. The decidua has a critical role to ensure proper maternal-fetal interactions and guides tro-
phoblast invasion, placental orientation and development [3]. The transdifferentiation process
of stromal cells is coordinated by the priming effect of the steroid hormones, Estradiol (E) and
Progesterone (P); and the signaling interaction with the implanting blastocyst [2, 4]. Although
numerous molecules of the signaling pathway necessary for decidual development have been
identified, the hierarchical instructions that coordinate ovarian hormone actions with the em-
bryo-uterine dialogue are not well understood.
The decidua presents different morphological and functional areas: the antimesometrial de-
cidua (AM) is characterized by compacted and round cells and is the site where the embryo im-
plants; the mesometrial decidua (M), a less compact area, is important for the development of
the vasculature and the ingrowth of the placenta. These two differently differentiated zones,
AM and M, are clearly separated by the junctional zone (J), which maintains a stromal charac-
ter. Similarly, the decidual area underneath myometrium (UM) remains also undifferentiated
conserving endometrial glands [5].
We previously described the role of progesterone receptors (PR), estrogen receptors (ER), in
ERK activation during in vivo decidualization [6]. We studied the changes in PR, ER and activat-
ed ERK (p-ERK) localization during the late kinetic of pregnancy and after treatment of pregnant
rats with pure progesterone or estrogen antagonist alone and in combination (subcutaneous-sc-
injection) and with the ERK1/2 phosphorilation inhibitor PD98059 (intraperitoneal-ip- injection).
We showed that PR and ER participate in growth and differentiation of the different rat decidual
regions and suggested a new function of p-ERK1/2 in regulating expression levels of ER α, thereby
keeping the proliferation capacity of stromal cells and limiting the differentiation process in speci-
fied regions of decidual tissues. In this paper we describe the relation between PR, ER α, their sig-
naling pathways and a novel drug interaction during the initial steps of decidualization by steroid
hormone antagonists administration at 5 and 6 dpc of rat pregnancy. Phenotypes of decidua de-
velopment produced by antagonist treatments were characterized by morphology, proliferation,
differentiation, angiogenesis and expression of signaling molecules.
Materials and Methods
Reagents
Hormone antagonists: Antiprogestin Onapristone (ONA) (ZK 98299, Bayer Schering, Germany);
Antiestrogen faslodex (ICI182780, ICI) (Tocris Bioscience, Bristol, UK). Solutions: RIPA buffer
(50 mM Tris/HCl, 150 mMNaCl, 1% NP-40, 0.25% Na-deoxycholate, 1 mM EDTA, 0.1% SDS)
supplemented with EDTA-free Complete Protease Inhibitor Cocktail and PhosSTOP Phosphatase
Inhibitor Cocktail (Roche, Mannheim, Germany); Phosphate-buffered saline (PBS; 1.3 mMNaH2-
PO4H2O, 9.7 mMNa2HPO4, 145.4 mMNaCl; pH 7.4); Citrate Buffer (8.2 mM Sodium Citrate,
1.8 mMCitric Acid; pH 6.0). Bradford protein assay kit (Bio-Rad Laboratories, California, USA).
RNeasy Midi-Kit (Qiagen, Hilden, Germany). Power SYBRMaster Mix (Applied Biosystems),
Hematoxylin (BIOPUR diagnostics, Buenos Aires, Argentina), Eosin (Cicarelli Laboratorios, Bue-
nos Aires, Argentina). Streptavidin peroxidase complex (Millipore, Billerica, NA, USA), 3.3 diami-
nobenzidine (DAB) (Dako, Glostrup, Denmark). Bovine serum albumin (BSA) (Sigma-Aldrich,
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St. Louis, MO, USA). The following primary antibodies were used: rabbit polyclonal C20 anti-
hPR (1:1000); rabbit polyclonal H190 anti-hPR (1:100); rabbit polyclonal MC20 anti-mER α
(1:2000, 1:100), rabbit polyclonal C14 anti-rERK2 (1:1000); mouse monoclonal PC10 anti-rPCNA
(1:1000), rabbit polyclonal C16 anti-hCyclinD3 (1:500) and rabbit polyclonal anti-FGF-2 (1:200)
were bought from Santa Cruz Biotechnology Inc. Rabbit polyclonal anti-CX43 (1:3000) was
bought from Sigma-Aldrich; rabbit monoclonal 14C10 anti-hGAPDH (1:3000) and rabbit mono-
clonal D13.14.4E against hERK1/2 phosphorylated at Thr202/Tyr204 (1:2000, 1:200) were ob-
tained from Cell Signaling Technology; mouse monoclonal M0724 anti-DESMIN (1:1000) was
purchased fromDako and rat polyclonal anti-CD31 (1:20) from Dianova. Rabbit polyclonal
ab15580 anti-KI67 (1:200) was bought from Abcam. Biotinilated secondary antibodies E0432
anti-rabbit (1:200), E0433 anti-mouse (1:100) and anti-rat (1:200) immunoglobulins were ob-
tained fromDako Inc. Horseradish peroxidase (HRP) linked secondary antibodies NA934 anti-
rabbit (1:3000) and NA931 anti-mouse (1:3000) immunoglobulins were purchased from GE
Healthcare Life Sciences.
Animal care
All animal experiments were approved by the Institutional Animal Care Committee of the
Instituto de Biología y Medicina Experimental and the Universitaetsklinikum Duisburg-Essen
and were carried out in accordance with local and state regulations for research with animals.
Adult female Wistar rats (Charles River Laboratories, Germany) were housed under con-
trolled temperature (22°C ± 1°C, atmospheric humidity of 55% ± 10%) and lighting (12 hs light:
12 hs dark cycles) conditions. The rats were fed with standard pellet food and ad libidum water.
Pregnancy
Mating was performed overnight and the following morning sperm was evaluated by vaginal
smear. The day of sperm finding was designated as day 0 post coitum (dpc). The 4 dpc preg-
nancies were confirmed by flushing the uterus and analyzing blastocyst presence. The 5, 6, 7, 8,
9, 10 and 20 dpc pregnancies were confirmed by the presence of implantation sites (ISs).
PR and ER antagonist treatments
The antiprogestin Onapristone (ONA) was dissolved in benzilbenzoat (20 mg/ml). For subcu-
taneous injection, 0.5 or 1 mg ONA were adjust to a final volume of 150 or 300 μl with peanut
oil, respectively. The antiestrogen ICI was dissolved in ethanol (20 mg/ml), the volume corre-
sponding to 0.5 mg was adjust to 500 μl with peanut Oil and injected subcutaneously. Rats
(n = 3) were injected with 1 or 0.5 mg ONA (ONA), 0.5 mg ICI (ICI), or 1 mg ONA + 0.5 mg
ICI (ONA+ICI) per day at days 5 and 6 pc. Control animals (n = 3) were injected with vehicle
(oil). Implantation sites were collected at day 7, 10 and 20 pc. The label ¨ONA¨ in the figures
represents 1 mg ONA treatment, unless specified.
Tissue Collection
Rats were killed by cervical dislocation under isofluran-anesthesia. Non-pregnant (NP), 2 and 4
dpc pregnant uterine horns were removed and cut into pieces and frozen in liquid nitrogen for
subsequent western blot analysis. Implantation sites from 6, 7, 8, 9, 10 and 20 dpc uterine horns
were dissected. ISs were collected and frozen in liquid nitrogen for western blot analysis and
total RNA extraction, or fixed in 4% paraformaldehyde (PFA) for morphological and immuno-
histochemical analysis. For 20 dpc morphological analyses, placentas (P) and embryos (E) were
collected and weighted. The relation P weight to E weight (P/E) was calculated.
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Western Blot Analysis
Protein extracts were obtained from tissue samples by homogenization (Polytron PT-MR 300,
Brinkmann Instruments, NY, USA) in RIPA buffer supplemented with EDTA-free Complete
Protease Inhibitor and Phosphatase Inhibitor Cocktail. Protein concentration was determined by
Bradford protein assay kit. SDS-PAGE and immunoblot analyses were performed to detect DES-
MIN, CYCLIN D3 (CCND3), PCNA, FGF-2, CX43, Progesterone receptor (PR), Estrogen recep-
tor alfa (ER α), GAPDH, phosphorylated ERK1/2 proteins (p-ERK1/2) and ERK2. Detection
was achieved with chemiluminescent substrate using X-ray films (Kodak, Stuttgart, Germany).
The band intensities were measured with ImageQuant 3.3 program (Amersham Pharmacia Bio-
tech, Arlington Heights, IL). GAPDH and ERK2 were use as loading controls. Relative values of
protein levels were express as fold change of treatment intensity arbitrary units over its respective
control (NP and oil).
RNA extraction and qRT-PCR
Total RNA was isolated from 7 dpc ISs (n3) using the RNeasy Midi-Kit according to the manu-
facturer’s instructions. The RNA was reverse transcribed and β-Actin, Prl8a2, Vegfa,Hand2 and
Bmp2 levels were quantified by quantitative Real Time-PCR (qRT-PCR) using the system of de-
tection ABI PRISM 7500 (Applied BiosytemsQ7). Cycle threshold (CT) values were calculated
with 7500 System Software Sequence Detection System 1.3 (Applied BiosytemsQ7) and absolute
quantifications were carried out using known quantities of standard copy DNA (cDNA), result-
ing values were expressed in femtograms (fg). β-Actin was used as an internal control. Relative
values of mRNA levels were express as fold change of treatment fg over its respective control
(oil). Amplification of cDNA was performed at 60°C using primers listed in S1 Table.
Histochemistry
After fixation in 4% PFA, ISs were dehydrated in a graded series of alcohol, and- embedded in
paraffin. Serial sections of 7 μm were deparaffinized, rehydrated in a graded series of alcohol
and stained with hematoxylin-eosin (H&E). Photographs were taken with an Axiophot micro-
scope (Zeiss, Jena, Germany). The area of different regions from the ISs was delimited as
shown in S1 and S2 Figs and quantified with ImageJ 1.43 software (National Institute of Health,
Bethesda, Maryland, USA). The extent of the different decidual regions was calculated in rela-
tion to the area of the whole decidua, designated as 100%.
Immunohistochemistry
For immunostaining, 7 μm paraffin sections were deparaffinized and rehydrated in a graded
series of alcohols. After rinsing with PBS, the endogenous peroxidase was blocked and the sec-
tions were incubated with 0.5% bovine serum albumin for 30 min. The sections were incubated
overnight at 4°C with the specific antibodies, rinsed in PBS (3 x 5 min), followed by incuba-
tion with a biotinylated secondary antibody for 30 min at RT and for further 30 min with a
streptavidin-peroxidase complex. Staining was visualized with 3.3 diaminobenzidine (DAB).
For the detection of CD31, KI67 and PR, the slices were boiled for 20 min in Citrate Buffer and
left at room temperature (RT) for 40 min before blocking with BSA. KI67 staining was counter-
stained with hematoxylin. Controls were performed omitting the primary antibody.
KI67 quantification
Pictures from the different decidual areas were taken from KI67 immunohistochemistry (IHC)
staining. KI67 positive signal was visualized as brown nuclei while non-proliferative cells were
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seen as blue (hematoxylin staining). The percentages of proliferative cells per area of the decid-
ua were quantified blinded to the treatment condition with the plugin Cell counter from Ima-
geJ 1.43 software. The calculated percentage represents the number of KI67 positive cells over
total number of cells per field (100 percent). A minimum of 3 fields was quantified for each
area analyzed in each IS.
Quantification of blood vessels and lacunas
Blood lacunas and CD31 positive areas were quantified with ImageJ 1.43 software. The
CD31-IHC images taken with the Axiophot microscope were adjusted to grey scale and then a
threshold was applied. The pixels with intensity above the threshold were turned into black
while the pixels with intensity below the threshold were turned into white. In the final image
CD31 positive staining and blood lacunas were black over a white background. The blood ves-
sels and lacunas area was calculated in relation to the area of the whole image, designated as
100 percent. Only vessels and lacunas from the J and M area (J+M) were quantified.
Statistical Analysis
Analysis of variance was used for statistical testing, followed by Tukey Multiple Comparison Test.
For frequency analysis in tables contingency analysis followed by chi-square test was performed.
Student's t-test was used in S2 Fig Differences were considered significant if P< 0.05. Statistical
Analysis was carried out with GraphPad Prim 4.0 (GraphPad Software Inc., La Jolla, CA, USA).
Results
Changes in the morphology and gene expression of markers of the
decidua after ER and PR antagonists effects
Our previous study using the antagonists of PR (Onapristone, ONA) and ER (ICI) during
early pregnancy between days 6 and 8 pc [6] indicated that the action of both ovarian hor-
mones would be more effective and pronounced on the decidualization process if applicated
earlier in pregnancy. It should also restrict time and manner of approaching molecular signal-
ing pathways. Thus we treated pregnant rats with progesterone receptor antagonist or estro-
gen receptor antagonist alone and in combination one day earlier than started above [6] on
days 5 and 6 pc and collected the implantation sites (ISs) on day 7 pc. In contrast to treatment
on days 6 and 7 pc ONA 1 mg/rat/day given one day earlier caused resorption of all ISs. ONA
treatment produced a regression in the tissue with a shrinkage of all decidual tissues, avoiding
the differences between AM, M and J observed in oil treated ISs (Figs 1A and 2). The ONA
treated ISs showed residues of decidual tissue without an embryo (Fig 1 and S1 Fig). As 1 mg/
rat/day caused total resorption of embryos, we reduced the ONA dose to 0.5 mg/day/rat with
the same application protocol. The lower dose did not interfere with the implantation and
decidualization process and resulted in normal ISs, with properly developed decidual areas
(S2 Fig), indicating that lower PR activity might be sufficient for the decidualization but dras-
tically lose effectiveness under a still undefined limit.
ICI-treated ISs developed all decidual regions, AM, M and J, with a more compacted devel-
opment of M (Figs 1A and 2), but showed an enhanced effect on the blood vessel formation at
the mesometrial part (M) of the decidua (Fig 1A and S1 Fig).
Surprisingly the combined action of ONA+ICI, which downregulated the action of both
hormones, reverted the embryo resorptions induced by ONA alone (Fig 1A and S1 Fig) and
produced the same cellular phenotype as oil treated animals (Fig 2). However, though all de-
cidual compartments were appropriately developed, the ISs were obviously smaller (38 ± 7%)
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compared to control (Fig 1 and S1 Fig). When counting the resorption sites as successful im-
plantations, the number of implantation sites/pregnant rat does not differ between the differ-
ent treatments (Fig 1B). This result was expected, considering that the time schedule of
treatments used did not interfere with the early implantation process [7].
Longitudinal decidual length, different decidual areas (AM: antimesometrial, M: mesome-
trial and US: undifferentiated stroma) (indicated in S1 and S2 Figs) of ISs were quantified for
all treatments. The ratio between AM and M to the complete decidua did not change in ICI, 0.5
mg ONA or ONA+ICI (Fig 1B and S2 Fig).
To analyze in detail the decidual proliferation dependency on ER and PR action we studied
two proliferation markers, KI67 antigen and PCNA (Fig 2 and S3 Fig). ONA-resorpted ISs show-
ed a lower percentage of KI67 positive nuclei cells (Fig 2A). Two areas were distinguished in the
resorpted ISs: a disorganized central area (c) and a border zone (b). The former (c) had more KI67
positive nuclei than the ones in the latter (b). Regarding the proliferation per functional decidual
Fig 1. Morphology effects of ONA, ICI and ONA+ICI on 7 dpc implantation sites after 5 and 6 dpc consecutive injections. A) Figures show H&E
staining of a representative 7 dpc IS from Oil, ONA, ICI and ONA+ICI treated rats. B) Quantitative analysis. Table shows the number of implantation sites/rat,
the number of resorptions/total number of ISs analyzed, the mean ± SEM length and total area of decidua and the percentage of tissue areas corresponding
to the different regions within the ISs relative to the area of total decidua. Images analyzed are shown in S1 Fig Data represent mean fold change ± SEM from
at least 3 independent rats/treatment. *, P < 0.05; **, P < 0.01; ***, P < 0.001; a, statistical differences v. Oil; b, statistical differences v. ONA; ns, no
statistical differences v. Oil; ND, No development of decidua;. AM, antimesometrial decidua; M, mesometrial decidua; J, junctional zone; UM, under
myometrium; US, undifferentiated stroma; pdz, primary decidual zone; Myo, myometrium; b, border of resorpted IS; c, centre of resorpted IS. mm,
millimeters; mm2, square millimeters. Bar = 1000 μm.
doi:10.1371/journal.pone.0124756.g001
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Fig 2. Effects of antagonist treatments on proliferation. Samples from 7 dpc Oil, ONA, ICI or ONA+ICI treated rats were analyzed for KI67 protein
expression. A) Details of KI67 immunostaining of M, J and AM zones from a representative 7 dpc IS from Oil, ICI and ONA+ICI treated rats; and the border (b)
and central (c) zones from a representative ONA-treated IS. Mean percentages ± SEM of positive KI67 cells are shown under each picture. B) KI67
quantification. Each point in the graph represents the percentage of the proliferative cells per field. Three fields per IS area were count and a minimum of 3
ISs were analyzed for each treatment. Fig 2A data represent mean fold change ± SEM from at least three independent rats/treatment, a minimum of 1 IS/rat
was analyzed. *, P < 0.05; **, P < 0.001. O+I, ONA+ICI; M, mesometrial decidua; J, junctional zone; AM, antimesometrial decidua; b, border area of
resorpted IS; c, center area of resorpted IS. Magnification bars = 400 μm; magnification bar = 20 μm.
doi:10.1371/journal.pone.0124756.g002
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area, only ICI treatment increased proliferation in the mesometrium (M), while ONA+ICI
decreased the proliferation in the antimesometrial area (AM) in respect to ICI treatment (Fig
2B). It is worth noting that the distribution of the proliferation percentages of Oil treated rats
showed lower dispersion than the percentages of ICI and ONA+ICI treated rats (Fig 2B). On
the other hand, protein levels of PCNA were significantly lower in ISs treated with ONA
compared with controls (S3 Fig). ICI and ONA+ICI showed only a tendency to diminish the
expression of PCNA proliferation marker (S3 Fig). These results are in accordance with a sig-
nificantly reduced decidualization observed in ONA and ONA+ICI treatment, and with a
slightly reduced developed decidual area in ICI treated rats (Fig 1B). While ER antagonism
seems to interfere only slightly with proliferation activity, impairment of PR action was most
drastic and resulted in complete resorptions, confirming that progesterone is the stimulating
hormone for endometrial stromal proliferation.
For a detailed view of the vasculature in the ISs of animals treated with the antagonists,
we performed immunohistochemistry against CD31, a marker for endothelial cells [8] (Fig
3A). CD31 expression confirmed the disorganization in the vasculature of the J+M area with
Fig 3. Effects of antagonist treatments on decidual vessels formation. A) Detail of junctional zone (J) of
H&E (upper panel) and CD31 immunostaining (lower panel) of a representative 7 dpc ISs from Oil, ICI and
ONA+ICI. B) Quantification of vessel and lacunas structures of J+M areas. Data represent the mean ± SEM
of the percentage of blood vessels and lacunas area from H&E images relative to total J+M area from at least
three independent rats/treatment. *, P < 0.05. M, mesometrial decidua; J, junctional zone. Bar = 100 μm.
Arrows heads indicate blood lacunas.
doi:10.1371/journal.pone.0124756.g003
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numerous dilated vessels and red cells in lacunas already observed in the histology of ICI treat-
ed ISs (Fig 1A, S1 Fig and Fig 3A). CD31 positive area and lacunas were quantified, showing an
increase in ICI-treated ISs in relation to Oil and ONA+ICI treatments (Fig 3B). There were no
significant differences between the vessels and lacunas area of Oil and ONA+ICI-treated rats
(Fig 3B). These results support a clear ICI effect on vasculogenesis in the mesometrial and junc-
tional area. CD31 IHC of ONA ISs showed plenty of newly-formed vessels in the border area
of the resorption, indicating a possible vascular reorganization process (S4 Fig).
We further characterized the decidualization process by studying decidual differentiation
(Fig 4A) and vascularization (Fig 4B) markers and their dependency on the ER and PR action.
For changes in decidual differentiation after ER and PR antagonists treatment we investigated
DESMIN (DES), a classical structural decidual marker [9], and CYCLIN D3 (CCND3), a poly-
ploidization and terminal differentiation marker [10], Connexin 43 (CX43), a gap junction
protein highly enriched in decidua and critical for decidual differentiation and angiogenesis
[11–13], and mRNA expression of Prl8a2, the decidual/trophoblast prolactin-related protein
abundantly expressed in decidua [14] (Fig 4A). During the progress of early pregnancy we ob-
served that protein expression of Desmin and CCND3markers increased in parallel with devel-
opment of decidua, reaching a maximum at 6–7 dpc for DES and at 7 dpc for CCND3
expression (S5 Fig). In the case of antagonist treated animals, ONA alone produced a remark-
ably reduced Desmin and CCND3 expression, and a smaller reduction in the combined treat-
ment (Fig 4A). CX43 was downregulated by ONA and ICI alone treatments (Fig 4A). Prl8a2
was downregulated in ONA resorpted sites, and was upregulated by ICI and ONA+ICI treat-
ments (Fig 4A). These results indicate that the smaller size of ONA+ICI ISs in relation to oil
treatment is due not only to a reduce proliferation but also to a loss of differentiation capacity
resulting in suboptimal developed ISs.
Regarding vascularization, we measured FGF-2 [15] protein and Vegfa [16] mRNA
(Fig 4B). Both markers of angiogenesis were upregulated in ISs from ONA treated rats
(Fig 4B). ICI treatment showed upregulation of FGF-2 while ONA+ICI treated rats showed
upregulated VegfamRNA expression (Fig 4B). The higher levels of FGF-2 and Vefga ob-
served in ONA treated animals could reflect the reorganization in morphology and vas-
culature of the=implantation chambers of ONA treated animals induced by the resorption
process. CD31 immunohistochemistry of ONA resorptions confirmed this vascular
reorganization (S4 Fig). The higher levels of FGF-2 and Vefga observed in ICI treated
animals could be due to a phenomenon exclusively restricted to vessel formation. The low
dose of ONA did not produce changes in differentiation and vascularization marker ex-
pression (S2 Fig).
Rescue effect of reduced PR action by additional ER antagonist
To further study the ICI rescue of ONA-induced ISs resorption, we analyzed different time
points (10 dpc and 20 dpc) after administration of ICI alone and in combination with ONA,
allowing pregnancy to continue nearly until labour. At 10 dpc we observed that ICI produced
normal and smaller ISs than oil treated rats (Fig 5). ONA+ICI produced heterogeneous results
summarized in Fig 5 and S6 Fig All the ISs analyzed (7/7IS/3rats) showed normal differentiated
decidua as confirmed by antimesometrial cells morphology, 71.4 percent (5/7IS/3rats) revealed
trophoblast differentiation and 42.9 percent (3/7IS/3rats) exhibited embryonic and extra-
embryonic tissue development, including proper placenta development, not correctly orientated
in some cases (Fig 5 and S6 Fig). Nevertheless, ICI and ONA+ICI-treated ISs were significantly
smaller than ISs of 10 dpc oil treated rats (Fig 5B). At day 20 pc development of ICI and 0.5 mg
ONA treated ISs continued to be normal, but the relationship between placenta and embryo
Progesterone and Estrogen Receptor Interaction during Decidualization
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Fig 4. Effects of antagonist treatments on differentiation and vascularization. Samples from 7 dpc Oil,
ONA, ICI or ONA+ICI treated rats were analyzed for protein and mRNA expression of differentiation and
vascularization markers. A) Differentiation markers: protein levels of CCND3, DESMIN, CX43 and mRNA
levels of Prl8a2. B) Vascularization markers: protein levels of FGF-2 and mRNA levels of Vegfa. Each
treatment protein levels relative to GAPDH or ERK2, or mRNA levels relative to β-Actin, were divided by the
corresponding Oil-treated value. Data represent mean fold change ± SEM from at least three independent
rats/treatment. Insets show pictures of a representative western blot. *, P < 0.05; **, P < 0.01; ***,
P < 0.001.
doi:10.1371/journal.pone.0124756.g004
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sizes increased with an increment in placenta size and a decrease in embryo size (Table 1 and S2
Fig). All 20 dpc embryos in every ONA+ICI treated rat analyzed were resorpted (S7 Fig).
Signaling pathways in ER and PR antagonist decidualization effects
In regard to the signaling pathways involved in the action of ovarian steroid receptors we ana-
lyzed the levels of PR and ER α during decidual differentiation. We found that ONA-induced
resorptive ISs expressed low levels of both PR receptors but the combined action of ONA+ICI
recovered the progesterone receptors to the levels of oil treated rats (Fig 6A). To note, the levels
of ER α however were downregulated by the antagonist treatments alone and in combination
when compared to controls but compared to single treatments ER α has recovered significantly
(Fig 6A). The localization for PR and ER α were analyzed by IHC of both receptors in 7 dpc ISs
treated with oil, ONA, ICI and ONA+ICI. All treatments presented positive signals for both re-
ceptors (Fig 7) as was previously described for 8 dpc [6]. PR was present in the cytoplasm and
nuclei of J, M and AM cells (Fig 7). In AM PR positive signal appeared also in the periphery of
the nuclei of AM differentiated cells (Fig 7). ER α localized in the cytoplasm and nuclei of
AM, J and M cells. ICI alone and in combination with ONA treatments did not change steroid
Fig 5. Morphology effects of ICI and ONA+ICI on 10 dpc rat implantation sites after 5 and 6 dpc
consecutive injections. A) Pictures show H&E staining of a representative IS treated with Oil, ICI and ONA
+ICI at 10 dpc. B) Quantitative analysis of 10 dpc ISs. Table shows the number of implantation sites/rat, the
mean ± SEM of total area of decidua and the proportion of ISs with AM, trophoblast and embryo and extra-
embryonic tissue (Embryo + Ee tissue). ONA+ICI ISs analyzed are shown in S6 Fig Data represent mean fold
change ± SEM from at least three independent rats/treatment, a minimum of 3 IS/rat was analyzed. **,
P < 0.01; a, statistical differences v. Oil; Differentiation (Number of ISs with development of the different areas
over total number of IS analyzed). AM, antimesometrial decidua; Myo, myometrium; X represents: AM,
Trophoblast or Embryo + Ee tissue; mm2, square millimeters. Bar = 1000 μm.
doi:10.1371/journal.pone.0124756.g005
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hormone receptors localization (Fig 7). ONA-induced resorpted ISs show low expression of PR
and ER α in the b and c zones (Fig 7).
The mRNA expression of genes previously described as being involved on PR and ER sig-
naling during decidualization—Bmp2 [17],Hand2 and FGF-2 [18]- was analyzed by qRT-PCR
and western blot respectively. Bmp2 showed a low expression in ONA 0.5 mg dose and this
downregulation was enhanced in resorptions, ICI treated animals showed no changes in com-
pared to controls, and the combined action of ONA+ICI upregulated Bmp2 expression (Fig 6B
and S2 Fig). Similarly, low levels of Hand2 expression were observed in the resorption sites of
ONA treated rats compared to normal 7 dpc ISs, nearly no change in ICI treated animals while
the combined action of ONA+ICI revealed a significant increase (Fig 6B).
ONA 0.5 mg treated rats revealed no changes in PRA, PRB and ER α protein expression (S2
Fig). Vegfa, Prl8a2 and Hand2, mRNAs were also not statistically different from oil treated rats
(S2 Fig).
We analyzed the effect of the antagonist treatments on the levels of activated ERK1/2 (p-
ERK1/2) by western blot and inmunohistochemistry (Fig 6C and 6D). The active isoform of
ERK, as well as PRA and B, was downregulated by ONA and ICI treatments alone and rescued
to control levels by ONA+ICI treatment (Fig 6C). ONA 0.5 mg treated rats revealed a diminu-
tion of p-ERK (S2 Fig). Immunodetection of activated ERK1/2 shows a strong signal in the pri-
mary decidual zone (pdz) and some nuclei staining in the junctional zone of oil-treated ISs at
day 7 pc (Fig 6D). No signal for p-ERK1/2 in ICI treated ISs was detected and a re-established
lower signal in ONA+ICI treated ISs (Fig 6D). These findings were confirmed by protein levels
seen in western blot analysis (Fig 6C).
We needed to find out whether ICI treatment ERK1/2 inactivation leads to vasculature ef-
fect or whether ICI vasculature failure caused ERK1/2 inactivation.
To explore the relation between ERK1/2 activation and the degree of decidua development
we analyzed p-ERK1/2 localization at 10 dpc. While in Oil treated rats the signal of p-ERK1/2
was restricted to the junctional area and to the area in contact with the developing placenta (S6
Fig), in ONA+ICI treated rats the signal spread toward the mesometrial side together with the
presence of vessel formation, marked by CD31 expression (S6 Fig). This could imply that
ERK1/2 activation during late decidua appears more meaningful for vasculature reorganization
when both antagonists are present.
Taken together, Bmp2,Hand2 and p-ERK1/2 significantly increased in ONA+ICI treated
animals and thus could contribute to the rescue effect in decidual morphology and function,
leading to the correct establishment of pregnancy.
Table 1. Effects of ICI and ONA+ICI on 20 dpc implantation sites after 5 and 6 dpc consecutive injections.
20 dpc Oil ICI ONA+ICI
# ISs/rat 13 ± 1 14 ± 1 11 ± 3R
Placenta weight (g) 0.64 ± 0.01 0.74 ± 0.02a*** ND
Embryo weight (g) 4.25 ± 0.06 3.96 ± 0.05a*** ND
P/E relation 0.15 ± 0.01 0.19 ± 0.01a*** ND
Quantitative analysis of 20 dpc embryos and placenta. Table shows the number of implantation sites/rat, the mean ± SEM of total area of decidua, the
Placenta and Embryo weight and the relation of Placenta weight to Embryo weight. Data represent mean fold change ± SEM from at least three
independent rats/treatment. g, grams. ND, No development of placenta and embryo.
*** P < 0.001.
a statistical differences v. Oil.
R only resorptions were found.
doi:10.1371/journal.pone.0124756.t001
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Discussion
The highlight of the present study is that loss of PR activity during early pregnancy, which re-
sulted in the resorption of implantation sites, was partially rescued by the abolishment of ER
action. The rescue, however, supported pregnancy only up to day 10 pc but further progress
was impaired by a failure in decidua, embryo and placenta development. ONA could produce
some toxic effects on implanted embryos, leading to embryo resorption during early pregnan-
cy. When the ONA dose was diminished and the pregnancy continued to 20 dpc the effect was
Fig 6. Effects of antagonist treatments on PR and ER expression and signaling pathways. Samples from 7 dpc Oil, ONA, ICI or ONA+ICI treated rats
were analyzed for protein and mRNA expression of steroid receptors and different genes related to known decidualization signaling pathways. A) Protein
expression levels of PRA, PRB and ER α were analyzed by western blot. B) Bmp2 andHand2mRNA expression levels were analyzed by qRT-PCR. C-D)
Variations in the levels of ERK1/2 activation were analyzed by western blot and Immunohistochemistry. Pictures in D) show staining for p-ERK1/2 on paraffin
sections of implantation sites from 7 dpc treated animals. For all figures, each treatment protein level value relative to ERK2 or mRNA level value relative to
β-Actinwas divided by the corresponding Oil-treated level. Data represent mean fold change ± SEM from at least three independent rats/treatment, a
minimum of 2 IS/rat was analyzed. Insets show pictures of a representative western blot. *, P < 0.05; **, P < 0.01; ***, P < 0.001. AM, antimesometrial
decidua; M, mesometrial decidua; pdz, primary decidual zone; -Ab, IHQ without specific antibody. Bar = 500 μm.
doi:10.1371/journal.pone.0124756.g006
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a significant reduction in embryo size and a significant increment in placenta size. Similar re-
sults were obtained in the case of 20 dpc ICI treatment. Maternal and embryo toxic effects
could lead to a miscommunication affecting proper pregnancy develop [1, 3, 4].
The ratio of progesterone to estrogen receptors seems to be most important for appropriate
decidualization. Even if both hormone receptors are blocked by their respective antagonists,
the remaining activity seems adequate for reduced but proper decidualization. Apart from re-
sorptions, the development of the regionalized decidua into different compartments is not im-
paired, a fact that points to a mutual influence of the ingrowing embryo and placenta on the
structural organization of this tissue.
PR- and ER-antagonist effects on PR and ER expression
Treatment with only one antagonist, whether ER or PR, resulted in a significant downregulation
of PRA/B and ER α receptor expression, confirming the regulatory influence of each hormone
on both receptors (Fig 8). Interestingly, simultaneous PR and ER antagonists administration, re-
cover the hormone receptors status nearly to the level of the control. This phenomenon could
Fig 7. Effects of antagonist treatments on PR and ER α localization. IHC for PR and ER α from 7 dpc Oil, ONA, ICI and ONA+ICI treated ISs were
analyzed for protein localization of steroid receptors. Pictures show a representative IS of each decidual area/treatment staining for PR and ERα on paraffin
sections of implantation sites from 7 dpc treated animals. AM, antimesometrial decidua; M, mesometrial decidua; J, junctional zone; b, border area of
resorpted IS; c, center area of resorpted IS;-Ab, IHQ without specific antibody. Bar = 20 μm.
doi:10.1371/journal.pone.0124756.g007
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contribute to the rescue of decidualization for it to proceed. These findings support the idea that
not only the absence of PR results in a progesterone-dependent deregulation programming but
also influences the regulation of ER action, which ends up in an abnormal development of the
decidua leading to loss of the pregnancy.
Downstream decidualization gene markers
The impaired decidual differentiation process is reflected by the changes in the expression of
downstream decidualization-related genes such asHand2 [19], Bmp2 [17], CCND3 [20], DES-
MIN, CX43 and Prl8a2 [14].
DESMIN and CCND3 increase upon decidualization progression and reach their higher ex-
pression at 6–7 dpc respectively. Both markers are significantly reduced upon all treatment
protocols and reflect the less differentiated decidual tissue observed in morphology. CX43 was
also diminished by the treatment with both antagonists alone. ONA treatment presents a single
and smaller band positive for CX43. This result could correspond to the non-phosphorylated
(P0) form in ONA regressed decidua and the larger bands present and predominately in other
treatment could correspond to P1 and P2 phosphorylated CX43 forms. ONA effect over CX43
isoforms in resorted ISs could be similar than the effects described by retinoic acid in human
endometrial stromal cells [21]. Our results agree with CX43 expression stimulated by estrogen
in preimplantation hormonal-mediated pathway versus embryo implantation-initiated path-
way [11]. On the other hand high expression of Prl8a2 in response to low activity of ER and PR
reinforces its importance in pregnancy adaptation to physiological stressors [22].
Regarding proliferation, percent of KI67 nuclear antigen positive signal at 7 dpc decidual
regions of Oil-treated ISs were in general lower than percents resulted in all other treatments.
This result contrasted with what was expected considering that Oil-treated ISs were bigger
Fig 8. Scheme depicting interaction between PR and ER pathways in decidualization. Individual
antagonist treatments evidenced PR and ER gene regulation pathways, meanwhile combined antagonist
treatment highlights the existence of P and E receptors pathways interaction. ONA +ICI treatment restores
ISs development by the activation of ¨compensatory pathways¨. This failsafe road could include regulation of
Hand2, Bmp2 expression, ERK activation and/or unidentified signaling molecules (X). Arrows heads, positive
regulation; blunt heads, negative regulation; point head; undefined regulation; black fill line, interactions
evidenced in this work; red dot line, pathways proposed.
doi:10.1371/journal.pone.0124756.g008
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than was observed for all other treatments, exception made of ICI that showed a similar size.
These results could indicate that the stromal cell proliferation in Oil-treated rats took place
before day 7 pc, while antagonist treatments (ICI and ICI+ONA) delayed the time of cell pro-
liferation. This is not the case with ONA treatment, which produces a diminution of size by
regression of the tissue. Levels of PCNA, another marker of cell proliferation, were signifi-
cantly reduced only in the decidua of ONA treated rats. The equally slightly lower levels in
the ICI or ONA+ICI treatments were not correlated to the differences in the size of decidual
areas measured in H&E cross sections. PCNA levels could also reflect the higher endoreplica-
tive state associated to a more differentiated state of Oil-treated ISs than that were observed
in antagonist-treated ISs.
Hand2 and Bmp2 followed a similar expression pattern after antagonist treatments with
downregulation after antiprogestin, but an enhanced expression after antiestrogen and, special-
ly, combined antagonist treatments. HAND2 protein has been shown to be localized in the
uterine stroma, and increases during decidualization in vitro in mouse and human [19]. Sup-
pression of Hand2 by mRNA interference resulted in a reduced differentiation of decidua [19].
Recently, Bagchi et al. [23] have identified Hand2 as a PR-regulated gene using the PR an-
tagonist RU486 and by P-treatment of ovariectomized mice. Further investigations using a
conditional knockout mouse revealed that mice lacking the progesterone-induced expression
ofHand2 had a continued stimulation of the estrogen pathway via the induction of ER α phos-
phorylation [18]. The dominance of ER α- signaling pathways is indicated by induction FGFs
and the preservation of epithelial proliferation, which resulted in impaired implantation.
Moreover, HAND2 has been shown to mediate steroid effects for pregnancy progression
[19]. Like in other studies, we found a downregulation ofHand2 and an upregulation of FGF-2
in ONA-induced resorptive ISs and an upregulation under progesterone dominance in ICI
treated animals. Inactivation of both, PR and ER action, further upregulates Hand2, which in-
dicates a feedback mechanism to compensate for the loss of ovarian hormone receptors (Fig 8).
BMP2, which belongs to the multifunctional transforming growth factor superfamily, and
its receptor has been shown to be stage specifically expressed in the decidua [24]. The use of
the antiprogestin RU486 demonstrated that BMP2 belongs to the downstream target genes of
P and is functionally involved in decidualization in mice and human [25]. Generating condi-
tional deletion of Bmp2, Lee et al. [17] demonstrated that the observed infertility of mice is due
to missing decidual response after blastocyst attachment. Furthermore, WNT-BMP2 pathway
regulated by COUP-TFII has been previously described in the regulation of ER activity by P,
showing its importance for blastocyst implantation and early pregnancy development [26, 27].
PR and ER antagonist effects on angiogenesis
The absence of ER activity produces abnormalities in the sinusoidal vessel formation of the
mesometrial decidua. Except for this abnormal vascularization, estrogen deprivation alone has
only minimal effects on the decidual morphology and pregnancy progression. These results
agree with previous studies that P is the ovarian hormone that plays a critical role during decid-
ualization [28]. Furthermore, beyond embryo attachment, Das et al. [29] described a central role
of locally synthesized estrogen during decidual angiogenesis. Thus, estrogen dominance in the
case of progesterone antagonist treatment seems to support synergistically the resorption pro-
cess by increasing the angiogenic potential. The abnormal vascularization observed in absence
of ER could be partially explained by the high levels of FGF-2 resulting of PR-dominance after
ICI treatment. Although FGF-2 expression has been previously associated to ER stimulation
[30], other molecules were described as FGF-2 regulators in rat decidua-i.e. PRL [31]-. PRL8A2
secreted in the antimesometrial zone of decidua [14] could have a paracrine role regulating
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FGF-2 expression at the mesometrial side [31]. As shown in the present study Prl8a2mRNA is
highly upregulated upon ICI treatment as well as in ONA+ICI treated rats. Together with the
high levels of Vegfa found in these decidual tissues, both growth factors initiate a higher vascu-
larization. Downregulation of CX43 in the presence of high Vegfa and FGF-2 could also contrib-
ute to disorganized vascularization. Whether HAND2 contributes to PRL expression regulation
is still not clear [19]. In our previous study we found evidence that activation of ERK1/2 play a
role in keeping the regionalized distribution of the decidualization process and thereby govern
the distribution of the vessels [6]. However, as shown here, activated ERK1/2 does not seem to
be a direct mediator of FGF-2 activity in our experimental conditions. On the other hand, the
lack in ERK1/2 activation caused by ICI could contribute to disorganize the neo-angiogenesis.
In addition, the upregulation of FGF-2 in the absence of p-ERK1/2 may be responsible for the
observed enhanced and abnormal decidual angiogenesis (Fig 8).
In summary (Fig 8), the partial rescue produced by ER antagonist when injected together
with PR antagonist reflects a suppressive interaction between both drugs. This hypothesis is sup-
ported by the suppressive effect of each hormone receptor on the opposite receptor and a tightly
counteracting expression on the downstream target genes. On the bases of these findings, we
propose that decidualization has evolved to an ‘optimal’ condition–i.e. maximizing growth de-
cidual cell rate in a given condition and time. Reduced production of differentiation players
such as Bmp2 andHand2 in ONA treated animals results in an ineffective use of cellular re-
sources and prevents pregnancy development (resorption). The loss of ERK activation needed
for the correct regionalization of the IS contributes to the final deleterious result. The subopti-
mal scenario in response to ONA+ICI treatment could lead to the activation of compensatory
¨rescue¨ pathways (Fig 8). However, overproduction of the rescue molecules,Hand2 and Bmp2,
could lead to an excessive use of resources for decidualization at the expense of other cellular
processes, i.e. proliferation, with a sub-optimal size of the implantation site in the case of ONA
+ICI treatment. The observation that, under growth inhibition produced by ONA in presence
of ICI, reduction in differentiation allows faster than ONA-alone-treatment growth of decidua
suggests that decidual player levels are not optimally but functionally regulated under these
hormonal conditions.
Supporting Information
S1 Fig. Morphology effects of ONA, ICI and ONA+ICI on 7 dpc implantation sites after 5
and 6 dpc consecutive injections. Pictures show H&E staining of 7 dpc IS from Oil, ONA, ICI
and ONA+ICI treated rats analyzed and quantified in Fig 1B. Black lines define the decidual
areas quantified. AM, antimesometrial decidua; M, mesometrial decidua; J, junctional zone;
UM, under myometrium; US, undifferentiated stroma; Myo, myometrium; b, border area of
resorpted IS; c, center area of resorpted IS. Bar = 500 μm.
(TIF)
S2 Fig. Morphology effects and PR, ER and p-ERK levels of 0.5 mg ONA on 7 and 20 dpc
implantation sites after 5 and 6 dpc consecutive injections. A) Pictures show H&E staining of
a representative 7 dpc IS from 0.5 mg ONA treated rats. B) Quantitative analysis of ISs shown in
A. Table shows the number of implantation sites/rat, the number of resorptions/total number of
ISs analyzed, the mean ± SEM of length and mean ± SEM of total area of decidua and the per-
centage of tissue areas corresponding to the different regions within the ISs relative to the area of
total decidua. Black lines define the decidual areas quantified. At least 3 independent ISs were
quantified. C) Quantitative analysis of the effects of 0.5 mg ONA on 20 dpc implantation sites
after 5 and 6 dpc consecutive injections. Table shows the number of implantation sites/rat, the
mean ± SEM of total area of decidua, the Placenta and Embryo weight and the relation of Placenta
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weight to Embryo weight. D) Protein expression levels of PRA, PRB, ER α, CX43, FGF-2, DES,
CCND3, GAPDH, ERK2 and activated ERK1/2 were analyzed by western blot and mRNA expres-
sion levels of Vegfa, Prl8a2, Bmp2 andHand2 analyzed by qRT-PCR. Data represent mean fold
change ± SEM from at least three independent rats/treatment, a minimum of 2 IS/rat was ana-
lyzed. , P< 0.05; , P< 0.001; a, statistical differences v. Oil; g, grams. AM, antimesometrium;
M, mesometrium; J, junctional zone; UM, under myometrium; US, undifferentiated stroma; Myo,
myometrium. Bar = 500 μm. mm, millimeters; mm2, square millimeters; g, grams.
(TIF)
S3 Fig. Effects of antagonist treatments on proliferation. Samples from 7 dpc Oil, ONA, ICI
or ONA+ICI treated rats were analyzed for protein expression of PCNA. In each treatment,
protein levels of PCNA relative to ERK2 were divided by Oil-treated value. Data represent
mean fold change ± SEM from at least three rats/treatment, a minimum of 2 IS/rat was ana-
lyzed. Insets show pictures of a representative western blot. , P< 0.05.
(TIF)
S4 Fig. Effects of ONA treatment on vessels formation. CD31 immunostaining counter-
stained with hematoxylin of a representative 7 dpc ISs from ONA-treated rats. Details are
shown in higher magnification. b, border area of resorpted IS; c, center area of resorpted IS.
Bar = 500 μm, magnification bar = 100 μm.
(TIF)
S5 Fig. Kinetics of decidualization markers, CCND3 and DESMIN, during early pregnancy.
Kinetics of Cyclin D3 and DESMIN protein expression during decidualization. Western blots
from Non Pregnant (0) and 2, 4, 6, 7, 8 and 9 days post-coitum (dpc) extracts were analyzed.
Each stage of pregnancy DESMIN and CCND3 protein levels relative to GAPDH were divided
by the NP corresponding level. Data in graphs represent mean fold change ± SEM from at least
three rats/day of pregnancy, a minimum of 2 IS/rat was analyzed. One representative blot is
shown for each protein. , P< 0.05; , P< 0.001.
(TIF)
S6 Fig. Morphology, CD31 and p-ERK1/2 immunolocalization in 10 dpc ISs after Oil and
ONA+ICI at 5 and 6 dpc consecutive injections. Pictures show H&E staining (upper panel)
and immunohistochemistry of CD31 (mid panel) and p-ERK1/2 (lower panel) of a repre-
sentative 10 dpc Oil-treated rat and of different 10 dpc ISs from ONA+ICI treated rats
quantified in Fig 5B. AM, antimesometrium; Myo, myometrium. Bar = 500 μm; magnifica-
tion bar = 100 μm.
(TIF)
S7 Fig. Morphology effects of ONA+ICI on 7, 10 and 20 dpc rat implantation sites after 5
and 6 dpc consecutive injections. Pictures show H&E staining of a representative 7, 10 and 20
dpc ISs from ONA+ICI treated rats. AM, antimesometrium; M, mesometrium; J, junctional
zone; Myo, myometrium; R, resorption. Bar = 500 μm. Arrow indicates resorpted area.
(TIF)
S1 Table. Primer sequences used for qRT-PCR.
(TIF)
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